UNITED STATES, November 18, 2026 — Ardent Health shares fell 19.75% on Wednesday after affiliates of Equity Group Investments and Ventas priced a secondary public offering of eight million shares at $14.50 each. The shares were being sold by existing holders, rather than issued as a primary fundraising by the company. RTTNews reported the offering price and market reaction.

Secondary offerings can place short-term pressure on a stock when investors assess the size of the sale, the price discount and the additional shares available for trading. Because the shares are sold by existing holders, proceeds generally go to those sellers rather than directly to the company’s balance sheet.

Ardent’s longer-term performance will continue to depend on its hospital operations, patient volumes, reimbursement rates, staffing costs and capital requirements. Investors will also monitor whether the offering changes the shareholder base or trading dynamics over the coming weeks.

Reporting note: This article reflects information available on November 18, 2026. Figures and market prices may change as companies and official agencies release updated information.